REG - Clean Power Hydrogen - Interim Results
21/09/2023 07:00
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230921:nRSU1332Na&default-theme=true
RNS Number : 1332N Clean Power Hydrogen 21 September 2023
The information communicated within this announcement is deemed to constitute
inside information as stipulated under the Market Abuse Regulations (EU) No.
596/2014 which is part of UK law by virtue of the European Union (withdrawal)
Act 2018. Upon the publication of this announcement, this inside information
is now considered to be in the public domain.
21 September 2023
Clean Power Hydrogen plc
("CPH2", the "Company" or the "Group)
Interim Results for the six months ended 30 June 2023
Clean Power Hydrogen plc (AIM: CPH2), the UK-based green hydrogen technology
and manufacturing group that has developed the IP-protected Membrane-Free
Electrolyser ("MFE"), is pleased to announce its unaudited results for the six
months ended 30 June 2023.
Financial Highlights
· Cash position remains strong at £12.9m
· £1.3m investment on development work in the six months to June
2023
· Loss of £1.6m in the six months to June 2023
Technology Highlights
· The MFE110, the Company's first scaled membrane free
electrolyser, is in the final stage of testing.
· Thorough testing of the MFE110 has identified upgrades and the
Company has successfully redesigned the cryogenic system as well as validated
the stack design.
· Results of the MFE110 have informed valuable enhancements to the
MFE220 design as expected.
· Following the delivery of the MFE110, the Company will turn its
focus to finalising the design and build programme of the MFE220, CPH2's 1MW
System.
· Applications now submitted to certifying bodies for CE marking, UKCA
marking, NI CE marking.
Significant engineering milestones have been reached during the period and
although delivery of the MFE110 has been delayed to ensure operational and
safety compliance, delivery, commissioning and installation of the unit at our
customer's site will take place imminently.
The commissioning process has given valuable design and operability feedback
which has resulted in further iterations of the MFE design. This redesign
process has been done in a methodical and diligent manner and led to a number
of components being reworked, re-engineered, and reordered, which in turn has
had a knock-on impact on the commissioning schedule especially when new
components have long lead times. However, the Company has largely finished
this process and the improvement in the components and design means that CPH2
is more confident now in its ability to fully commercialise the product. The
data and the learnings the team has accrued place the Company in a much
stronger position to roll out the technology at CPH2's own facilities and at
licence holder facilities.
Commercially, CPH2 is in a strong position. The Group's pipeline and order
book is expected to increase once customers are able to verify having a
working unit in operation in the field. In tandem, the Company is working with
its licence partners to deliver the blueprints for their own production and
hope to have these ready for late Q4 2023 or early Q1 2024. As a result of the
delays the Company does not expect any significant income in FY2023.
Change of Name of Nominated Adviser and Broker
The Company also announces that Cenkos Securities, its Nominated Adviser and
Broker, has changed its name to Cavendish Securities plc following completion
of its own corporate merger.
For more information, please contact:
Clean Power Hydrogen plc via Camarco
Jon Duffy, Chief Executive Officer
James Hobson, Chief Financial Officer
Cavendish Securities plc - NOMAD & Broker
Neil McDonald +44 (0)131 220 9771
Peter Lynch +44 (0)131 220 9772
Adam Rae +44 (0)131 220 9778
Camarco PR + 44(0) 20 3757 4980
Billy Clegg
Owen Roberts
Lily Pettifar
To find out more, please visit: https://www.cph2.com (https://www.cph2.com)
Overview of CPH2
CPH2 is the holding company of Clean Power Hydrogen Group Limited ("Clean
Power") which has almost a decade of dedicated research and product
development experience. This experience has resulted in the creation of
simple, safe and sustainable technology which is designed to deliver a modular
solution to the hydrogen production market in a cost-effective, scalable,
reliable and long-lasting manner. The Group's strategic objective is to
deliver the lowest LCOH in the market in relation to the production of green
hydrogen. The Group's MFE technology is already commercially available and
demonstrating cost efficiencies and technological advantages. CPH2 is listed
on the AIM market and trades under the ticker LON:CPH2.
Chief Executive's Statement
Technology update
Work during the period has concentrated on completion of the MFE110
electrolysers, our 0.5 MW system being used to validate the technology at
scale and verify the design, following which they will be shipped to customer
sites for site validation.
The design of the MFE110 was completed in Q1 2023, following which the Company
undertook the pre-commissioning and then commissioning of the system under the
watchful eye of Paul Cassidy, our CTO who joined in March 2023.
The pre-commissioning and commissioning process is a necessary procedure to
undertake in all engineering projects as it is the first time we are
commissioning our groundbreaking technology at scale. The commissioning
process has given valuable design and operability feedback which has resulted
in further iterations of the MFE design. This design evolution has resulted in
a longer commissioning process than first anticipated, however, we are
confident that these iterations put the technology on a sound basis.
Every component and system - including each valve, gauge, pipe, electrical
wire and pump - has been tested to ensure it is correctly installed and
functioning according to its specification. Any components that were not
working according to the design specification, or otherwise as expected, were
reviewed by the engineering and research & development departments, who
found a solution to resolve the issue. At times this resulted in a redesign of
the component, which then were procured, for which in some cases incurred
additional lead time.
The Company is executing a staged commissioning process testing firstly the
stacks, then the stacks with the dryers, the cryogenics, and then finally
bringing together the stacks, dryers, and cryogenics to have the complete
system working together, successfully generating separated hydrogen and oxygen
gases. This has given the Company the opportunity to make modifications
before bringing the entire system online.
Over the last five months we have been working through this process in a
methodical way, successfully resolving issues found, while ensuring that
safety is paramount, which has resulted in an improvement to the unit
operability, validation of stack design, and design improvements of the
cryogenic system.
I am pleased to advise that as at the date of this report, the Company has
reached the final stage of the commissioning process, which will be to
generate separated hydrogen and oxygen gases of its first MFE110 electrolyser
in the coming weeks, having already successfully generated mixed gas.
Significant firsts have been achieved, and having successfully gone through
nearly the whole commissioning process, confidence is high as we embark on the
closing stage of commissioning.
The next stage of the process is achieving Factory Acceptance Testing which
includes customer acceptance, upon which the first MFE110 will be shipped to
the customer site.
The commissioning process has taken two months longer than expected but has
been a crucial learning experience for the Company which has instilled the
necessary disciplined approach which will prove valuable going forward. In
addition, the successful proving of the technology at scale gives great
confidence in the Company's 1MW system, the MFE220.
Work has continued on completing the design of the MFE220, and the issues that
were found and resolved in the commissioning process of the MFE110, is
informing the MFE220's development. We are expecting to complete the design
and then begin building the unit in Q4 2023, with commissioning and customer
delivery in the new year.
Commercial update
We have been working closely with our licence partners, as well as our
customers and their respective engineering consultants, and appreciate the
strong support we have received.
During the period we signed a 10-year licensing deal with Fabrum, an advanced
energy company with deep expertise in cryogenics and an important customer of
CPH2, alongside two MFE220 orders. The licensing deal allows Fabrum to
manufacture membrane-free electrolysers in their factory in Christchurch, New
Zealand as well as a non-exclusive sales licence for Australia and New
Zealand. Under the agreement Fabrum will manufacture either upon a CPH2 order
or their own sale. The MFE220s built by Fabrum will be in accordance with
Australian & New Zealand standards, and upon completion of the design and
compliance work, there will be a membrane free electrolyser ready for the
Australian and New Zealand market. Fabrum has since secured its first customer
order under the licencing agreement from Obayashi Construction Company.
Financial review
The Company has prudently and carefully managed its cash resources during the
period, ensuring the cash spend is controlled and focused on our route to
commercialization. We remain in a strong cash position with cash resources of
£12.9m at 30 June 2023 (comprising term deposits of £8m and cash and cash
equivalents of £4.9m), a reduction of £2.4m from 31 December 2022 when the
cash resources of the Company were £15.3m. The Company incurred a loss of
£1.6m for the six months ended 30 June 2023, an increase of £0.5m from the
comparative period, but down from the loss of £2.3m incurred in H2 2022. The
Company invested £1.3m in development work during the period.
Conclusion and Outlook
It has been a crucial time for the Company, and whilst we have had delays, strong strides have been made during the period in proving at scale the differentiated, groundbreaking membrane free electrolyser technology on the back of a disciplined engineering approach. Our key focus for the rest of the year is to complete and ship MFE110s, to have a scaled working electrolyser at a customer site, and to complete the design of the CPH2 1MW system, the MFE220, in line with our stated milestones. The enormous global hydrogen opportunity only continues to strengthen and we are confident that our technology provides a compelling, disruptive and attractive offering.
As we sit at the cusp of commercialising a truly ground-breaking technology in
the hydrogen sector, I would like to thank to all our staff whose passion is
inspiring and who have worked tirelessly to progress the technology and the
Company.
Jon Duffy
Chief Executive Officer
Consolidated Statement of Comprehensive Income
FOR THE PERIOD ENDED 30 JUNE 2023
Note 6 months ended 6 months ended Year ended
30 June 2023 30 June 2022 31 December 2022
Unaudited Unaudited Audited
£'000 £'000 £'000
Revenue - - -
Cost of sales - - -
Gross profit - - -
Other operating income 2 2 -
Administrative expenses excluding exceptional items (2,262) (2,158) (4,765)
Exceptional net credit 4 - 987 986
Total administrative expenses (2,262) (1,171) (3,779)
Operating loss (2,260) (1,169) (3,779)
Finance income 163 91 216
Finance expense (24) (28) (55)
Loss before taxation (2,121) (1,106) (3,618)
Taxation 5 512 - 174
Loss for the financial period (1,609) (1,106) (3,444)
Items that may be reclassified subsequently to profit or loss:
Foreign currency translation differences 12 (9) (19)
Fair value decrease in respect of investments (42) - (3)
Total comprehensive expense for the period (1,639) (1,115) (3,466)
Basic and diluted earnings per share (pence) 6 (0.60) (0.45) (1.35)
The accompanying notes are an integral part of these condensed consolidated
financial statements.
Consolidated Statement of Financial Position
AS AT 30 JUNE 2023
Note 30 June 2023 30 June 31 December 2022
2022
Unaudited Unaudited Audited
£'000 £'000 £'000
Assets
Non-current assets
Intangible assets 7 6,828 1,527 5,476
Property, plant and equipment 1,626 1,347 1,387
Fair value through OCI investments 8 1,455 - 1,497
Trade and other receivables 120 120 120
10,029 2,994 8,480
Current assets
Inventories 9 2,443 3,889 2,363
Trade and other receivables 10 2,304 2,085 3,239
Current asset investments 8,000 21,000 13,500
Cash and cash equivalents 4,907 2,175 1,790
17,654 29,149 20,892
Total assets 27,683 32,143 29,372
Liabilities
Current liabilities
Trade and other payables (717) (894) (844)
Deferred income (1,802) (2,636) (1,858)
Lease liabilities (124) (117) (121)
(2,643) (3,647) (2,823)
Non-current liabilities
Deferred income (630) (278) (641)
Lease liabilities (673) (797) (737)
(1,303) (1,075) (1,378)
Total liabilities (3,946) (4,722) (4,201)
Net assets 23,737 27,421 25,171
Equity
Called up share capital 2,682 2,654 2,654
Share premium account 27,707 27,638 27,638
Merger reserve 3,702 3,702 3,702
Currency translation reserve (3) (5) (15)
Accumulated loss (10,351) (6,568) (8,808)
Total equity 23,737 27,421 25,171
The accompanying notes are an integral part of these condensed consolidated
financial statements.
Consolidated Statement of Changes in Equity
FOR THE PERIOD ENDED 30 JUNE 2023
Called up share capital Share premium account Merger reserve Foreign currency reserve Accumulated loss Total
equity
£'000 £'000 £'000
£'000 £'000
£'000
Balance as at 1 January 2022 9 5,545 - 4 (5,910) (352)
Loss for the financial year - - - - (3,444) (3,444)
Other comprehensive expense - - - (19) (3) (22)
Total comprehensive expense for the year - - - (19) (3,447) (3,466)
Share based payments - - - 549 549
Capital reorganisation 1,843 (5,545) 3,702 - - -
Issue of share capital 802 27,638 - - - 28,440
Total contributions by owners 2,645 22,093 3,702 - 549 28,989
Balance as at 31 December 2022 2,654 27,638 3,702 (15) (8,808) 25,171
Loss for the financial period - - - - (1,609) (1,609)
Other comprehensive expense - - - 12 (42) (30)
Total comprehensive expense for the period - - - 12 (1,651) (1,639)
Share based payments - - - - 108 108
Issue of share capital 28 69 - - - 97
Total contributions by owners 28 69 - - 108 205
Balance as at 30 June 2023 2,682 27,707 3,702 (3) (10,351) 23,737
Comparatives for the six months ended 30 June 2022 are provided separately
below:
Called up share capital Share premium account Merger reserve Foreign currency reserve Accumulated loss Total
Equity
£'000 £'000 £'000
£'000 £'000
£'000
Balance as at 1 January 2022 9 5,545 - 4 (5,910) (352)
Loss for the financial period - - - - (1,106) (1,106)
Other comprehensive expense - - - (9) - (9)
Total comprehensive expense for the year - - - (9) (1,106) (1,115)
Share based payments - - - - 448 448
Capital reorganisation 1,843 (5,545) 3,702 - - -
Issue of share capital 802 27,638 - - - 28,440
Total contributions by owners 2,645 22,093 3,702 - 448 28,888
Balance as at 30 June 2022 2,654 27,638 3,702 (5) (6,568) 27,421
Consolidated Cash Flow Statement
FOR THE PERIOD ENDED 30 JUNE 2023
6 months ended 30 June 2023 6 months ended 30 June 2022 Year ended
31 December 2022
Unaudited Unaudited Audited
£'000 £'000 £'000
Cash flow from operating activities
Loss for the financial period (1,609) (1,106) (3,444)
Adjustment for:
Depreciation and amortisation 177 109 249
Loss on disposal - 10 5
Share based payments 108 (1,517) (1,416)
Foreign exchange 16 - (25)
Net finance income (139) (63) (161)
Taxation credit (512) - (174)
Changes in working capital:
Increase in inventories (80) (1,807) (281)
Decrease/(increase) in trade and other receivables 1,273 (1,381) (2,361)
(Decrease)/increase in trade and other payables (194) 742 293
Cash used in operations (960) (5,013) (7,315)
Income tax received 174 143 143
Net cash used in operating activities (786) (4,870) (7,172)
Cash flows from investing activities
Current asset investments disinvested/(made) 5,500 (21,000) (13,500)
Purchase of property, plant and equipment (388) (129) (292)
Purchase of intangible assets (1,384) (354) (4,316)
Purchase of investments - - (1,500)
Net cash generated from/(used in) investing activities 3,728 (21,483) (19,608)
Cash flows from financing activities
Issue of share capital (net of costs) 97 28,440 28,440
Interest received 163 91 216
Related party loan repaid - (382) (382)
Interest paid (24) (28) (55)
Payment of lease liabilities (61) (73) (129)
Net cash generated from financing activities 175 28,048 28,090
Net increase in cash and cash equivalents 3,117 1,695 1,310
Cash and cash equivalents at the beginning of the period 1,790 480 480
Cash and cash equivalents at the end of the period 4,907 2,175 1,790
Notes to the Condensed Interim Financial Statements
FOR THE PERIOD ENDED 30 JUNE 2023
1 Corporate information
Clean Power Hydrogen plc is a public company incorporated in the United
Kingdom and listed on the Alternative Investment Market ("AIM"). The
registered address of the Company is Unit D Parkside Business Park, Spinners
Road, Doncaster, England, DN2 4BL. The principal activity of the Company is as
a holding company for subsidiaries engaged in the development of a patented
method of hydrogen and oxygen production together with the development of a
gas separation technique which enables hydrogen to be produced as 'Green
Hydrogen' and oxygen to medical grade purity.
2 Basis of preparation
This unaudited condensed consolidated interim financial information for the
six months ended 30 June 2023 and 30 June 2022 has been prepared in accordance
with UK adopted international accounting standards ('IFRS') including IAS 34
'Interim Financial Reporting'.
The accounting policies applied by the Group include those as set out in the
consolidated financial statements for the Group for the year ended 31 December
2022 and are consistent with those to be used by the Group in its next
financial statements for the year ending 31 December 2023.
There are no new standards, interpretations and amendments which are not yet
effective in these financial statements, expected to have a material effect on
the Group's future financial statements.
The financial information does not contain all of the information that is
required to be disclosed in a full set of IFRS financial statements. The
financial information for the six months ended 30 June 2023 and 30 June 2022
is unaudited and does not constitute the Group or Company's statutory
financial statements for those periods.
The comparative financial information for the full year ended 31 December 2022
has, however, been derived from the audited statutory financial statements for
Clean Power Hydrogen plc for that period. A copy of those statutory financial
statements has been delivered to the Registrar of Companies. The auditor's
report on those accounts was unqualified and did not contain a statement under
section 498(2)-(3) of the Companies Act 2006.
These policies have been applied consistently to all periods presented, unless
otherwise stated.
The interim financial information has been prepared under the historical cost
convention with the exception of the fair values applied in accounting for
share based payments and investments. The financial information and the notes
to the historical financial information are presented in thousands of pounds
sterling ('£'000'), the functional and presentation currency of the Group,
except where otherwise indicated.
Going Concern
The Group's forecasts and projections to 31 December 2024 based on the current
trends in development and trading and after taking account of the funds
currently held, show that the Group will be able to operate within the level
of cash reserves.
The Directors therefore have a reasonable expectation that the Group have
adequate resources to continue in operational existence for the foreseeable
future and consider the going concern basis to be appropriate.
3 Segment reporting
IFRS 8, Operating Segments, requires operating segments to be identified on
the basis of internal reports that are regularly reviewed by the company's
chief operating decision maker. The chief operating decision maker is
considered to be the executive Directors.
The Group at this stage comprises only one operating segment for the
development and sale of equipment for the electrolytic production of clean
hydrogen and oxygen. This is monitored by the chief operating decision maker
and strategic decisions are made on the basis of adjusted segment operating
results.
4 Exceptional costs and credits
30 June 2023 30 June 31 December 2022
2022
Cash settled LTIP credit - 1,965 1,965
Accelerated share based payment on IPO - (374) (374)
IPO related costs - (604) (605)
- 987 986
Pre IPO, the Group had an LTIP in place for a director with a cash-settled
bonus arrangement payable, linked to the Group value and share price over the
3 year period to September 2023. This was replaced with parent company options
with new terms and on cancelling the arrangement resulted in the reversal of
previous charges and an exceptional credit to income of £1,965,000.
5 Taxation
Tax credits in respect of research and development expenditure have been
recognised when submitted and on receipt to date whilst experience of claims
being collated and accepted is gained. The credit for the period to 30 June
2023 relates to the claim submitted for the year ended 31 December 2022 and
the credit for the year ended 31 December 2022 to the claim submitted and
received for 2021.
6 Earnings per share
30 June 2023 30 June 31 December 2022
2022
Loss used in calculating earnings per share (£'000) (1,609) (1,106) (3,444)
Weighted average number of shares for basic EPS ('000) 266,422 245,054 255,321
Basic and diluted loss per share (pence) (0.60) (0.45) (1.35)
There is no dilutive effect on a loss. There are potentially dilutive options
in place over 22,333,279 ordinary shares at 30 June 2023.
7 Intangible fixed assets
Development costs Patents Software Total
£'000 £'000
£'000 £'000
Cost
At 1 January 2023 5,291 171 55 5,517
Additions 1,276 108 - 1,384
Reclassification (5) 5 - -
Exchange movements - (4) - (4)
At 30 June 2023 6,562 280 55 6,897
Accumulated depreciation
At 1 January 2023 - 21 20 41
Charge for the period - 21 7 28
At 30 June 2023 - 42 27 69
Net book amount
At 30 June 2023 6,562 238 28 6,828
At 31 December 2022 5,291 150 35 5,476
The development costs relate to the direct expenditure incurred on the
Group's membrane free electrolysis technology.
8 Investments held at fair value through other comprehensive income
£'000
As at 1 January 2023 1,497
Movement in fair value (42)
Fair value at 30 June 2023 1,455
The Company holds 1,412,429 ordinary £0.02 shares in ATOME Energy plc,
representing 3.5% of its issued share capital at 30 June 2023 (3.9% at 1
January 2023). ATOME Energy plc is listed on AIM and is focused on the
production, marketing and distribution of green hydrogen and ammonia.
The fair value at 30 June 2023 and 1 January 2023 is measured using the quoted
price on the AIM market at that date (a level 1 input using the price from an
active market).
9 Inventories
30 June 2023 30 June 31 December 2022
2022
Group and Company £'000 £'000 £'000
Raw materials and consumables 1,692 570 1,692
Work in progress 751 3,319 671
2,443 3,889 2,363
No impairment of inventory has arisen.
Work in progress represents the costs incurred in the production of machines
for confirmed orders not yet completed at the balance sheet date.
10 Trade and other receivables
30 June 2023 30 June 31 December 2022
2022
Current £'000 £'000 £'000
Trade receivables 81 - 84
Other receivables 849 688 2,053
Tax recoverable 512 - 174
Prepayments and accrued income 862 1,397 928
2,304 2,085 3,239
Non-current
Other receivables 120 120 120
There has been no significant revenue to 30 June 2023 and there have been no
impairment charges nor expected credit loss provisions made, as the credit
risk in respect of trade and other receivables is considered low. The
Directors consider that the carrying amount of trade and other receivables
approximates to their fair value.
£475,000 of other receivables and deferred income relates to cash from a
customer held in escrow subject to completion of the order.
11 Related party transactions
Directors remuneration during the 6 month period ended 30 June 2023 amounted
to £337,000 (6 month period ended 30 June 2022 : £367,000).
Independent Review Report to Clean Power Hydrogen plc
FOR THE PERIOD ENDED 30 JUNE 2023
Conclusion
Based on our review, nothing has come to our attention that causes us to
believe that the condensed set of financial statements in the half-yearly
report for the six months ended 30 June 2023 is not prepared, in all material
respects, in accordance with UK adopted International Accounting Standard 34,
"Interim Financial Reporting" and the requirements of the AIM Rules for
Companies.
Basis for conclusion
We conducted our review in accordance with International Standard on Review
Engagements (UK) 2410 "Review of Interim Financial Information Performed by
the Independent Auditor of the Entity", issued for use in the United Kingdom.
A review of interim financial information consists of making enquiries,
primarily of persons responsible for financial and accounting matters, and
applying analytical and other review procedures. A review is substantially
less in scope than an audit conducted in accordance with International
Standards on Auditing (UK), and consequently does not enable us to obtain
assurance that we would become aware of all significant matters that might be
identified in an audit. Accordingly, we do not express an audit opinion.
As disclosed in note 2, the annual financial statements of the group are
prepared in accordance with UK adopted IASs. The condensed set of financial
statements included in this half-yearly financial report has been prepared in
accordance with UK adopted International Accounting Standard 34 "Interim
Financial Reporting".
Conclusions related to going concern
Based on our review procedures, which are less extensive than those performed
in an audit as described in the Basis of conclusion section of this report,
nothing has come to our attention to suggest that management have
inappropriately adopted the going concern basis of accounting or that
management have identified material uncertainties relating to going concern
that are not appropriately disclosed.
This conclusion is based on the review procedures performed in accordance with
ISRE (UK) 2410, however future events or conditions may cause the group to
cease to continue as a going concern.
Responsibilities of directors
The directors are responsible for preparing the half-yearly financial report
in accordance with the AIM Rules for Companies.
In preparing the half-yearly financial report, the directors are responsible
for assessing the group's ability to continue as a going concern, disclosing,
as applicable, matters related to going concern and using the going concern
basis of accounting unless the directors either intend to liquidate the group
or to cease operations, or have no realistic alternative but to do so.
Auditor's responsibilities for the review of the financial information
In reviewing the half-yearly report, we are responsible for expressing to the
group a conclusion on the condensed set of financial statement in the
half-yearly financial report. Our conclusion, including our Conclusions
relating to going concern, are based on procedures that are less extensive
than audit procedures, as described in the Basis for conclusion paragraph of
this report.
Use of our report
Our report has been prepared in accordance with the terms of our engagement to
assist the Company in meeting the requirements of the rules of the London
Stock Exchange AIM Rules for Companies for no other purpose. No person is
entitled to rely on this report unless such a person is a person entitled to
rely upon this report by virtue of and for the purpose of our terms of
engagement or has been expressly authorised to do so by our prior written
consent. Save as above, we do not accept responsibility for this report to any
other person or for any other purpose and we hereby expressly disclaim any and
all such liability.
PKF Littlejohn LLP
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END IR BCGDCSDDDGXGRecent news on Clean Power Hydrogen
See all newsREG - Clean Power Hydrogen - Final Results
AnnouncementREG - Clean Power Hydrogen - Appointment of Chief Commercial Officer
AnnouncementREG - Clean Power Hydrogen - Notice of Results
AnnouncementREG - Clean Power Hydrogen - Level 2 of Site Acceptance Test Completed
AnnouncementREG - Clean Power Hydrogen - Level 1 of Site Acceptance Test Completed
Announcement